NeoGenomics, Inc. (NEO) Stock Price

NEOStock
$16.79+148.26%52W
Market Cap$2.16B
P/E
PEG Ratio2.09
Div yield
Beta1.83

NEO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)48.70%
Price vs S&P 500 (4W)19.41%
PEG Ratio2.09
VGM Score57.50

NEO Earnings Surprise History

Q2 250.03est. 0.02
Q3 250.03est. 0.02
Q4 250.06est. 0.04
Q1 260.01est. 0.00
Q2 260.05est. 0.03

NEO Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.82
3.94
3.94
3.94

Industry Peers — Testing Laboratories(3)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
NEONeoGenomics, Inc.
DBA$16.79
ULSUL Solutions Inc.DBC$73.99
AIDX20/20 Biolabs, Inc. Common StockD$0.53
BNBXBNB Plus Corp. Common StockDF$0.14

About NeoGenomics, Inc.

NeoGenomics Inc provides comprehensive oncology diagnostic testing and services through laboratories in the United States and United Kingdom. The company's offerings include clinical cancer testing, molecular and next-generation sequencing testing, professional interpretation, consultative services, clinical trial support, validation services, and oncology data solutions.